Pasithea Therapeutics Announces Results from 2023 Annual
Disclosure related to the annual meeting of Pasithea Therapeutics (Nasdaq: KTTA)...
Source: globenewswire.com
Page 2 - Patrick Gaynes News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Patrick Gaynes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Patrick Gaynes Today - Breaking & Trending Today
Pasithea Therapeutics Announces Adjournment of 2023 Annual
Pasithea Therapeutics adjourns 2023 annual meeting of stockholders....
Source: globenewswire.com
Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders
SOUTH SAN FRANCISCO, Calif. and MIAMI, Nov. 29, 2023 -- Pasithea Therapeutics Corp. , today announced that its annual meeting of stockholders held on November 29, 2023 was convened and then...
Source: marketscreener.com
60 Degrees Pharmaceuticals Suspends Phase IIB Study of
60 Degrees Pharma Suspends Phase IIB COVID Study, Pivots to Commercialization of Treatments for Malaria and Tick-borne Illness...
Source: globenewswire.com
60 Degrees Pharma Withdraws COVID Phase IIB IND, Will Resubmit Pending Assessment of Ability to Meet FDA Requirements - 60 Degrees (NASDAQ:SXTP), 60 Degrees (NASDAQ:SXTPW)
Prompted by advice from FDA regarding study design, 60P Australia Pty Ltd, a majority-owned subsidiary of 60 Degrees Pharmaceuticals, has withdrawn its IND for ACLR8-LR, a Phase IIB study of the use of tafenoquine in
Source: benzinga.com